BCIQ Profiles

Company Profile Report

Repurposing hypertension drugs to block cytokine release syndrome

Johns Hopkins University School of Medicine researchers showed that hypertension drug Demser metyrosine and an endogenous peptide in testing for hypertension could prevent cytokine release syndrome, a toxicity associated with immunotherapies, without compromising efficacy.

Cytokine

Read the full 346 word article

How to gain access

Continue reading with a
two-week free trial.